Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Health Fund

+ Add to Watchlist

FRAHEAA:LN

1,599.00 GBp 15.00 0.95%

As of 00:59:30 ET on 03/03/2015.

Snapshot for AXA Framlington Health Fund (FRAHEAA)

Year To Date: +7.90% 3-Month: +8.27% 3-Year: +25.63% 52-Week Range: 1,112.66 - 1,588.00
1-Month: +2.52% 1-Year: +28.69% 5-Year: +17.96% Beta vs FTWBWRLD: 0.91

Mutual Fund Chart for FRAHEAA

No chart data available.
  • FRAHEAA:LN 1,599.00
  • 1M
  • 1Y
Interactive FRAHEAA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRAHEAA

AXA Framlington Health Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to achieve capital growth. It invests in producers of pharmaceuticals, bio-technology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies along ethical guidelines.

Inception Date: 04-03-1987 Telephone: 44-207-374-4100
Managers: GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRAHEAA

NAV (on 2015-03-03) 1,599.00
Assets (M) (on 2015-01-30) 511.60
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for FRAHEAA

Dividend Type Accumulation
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRAHEAA

Front Load 5.50
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FRAHEAA

Filing Date: 01/30/2015
Name Position Value % of Total
Roche Holding AG 162,022 29,161,200 5.700%
Gilead Sciences Inc 373,839 26,091,600 5.100%
Novartis AG 368,410 24,045,200 4.700%
Amgen Inc 147,131 14,836,400 2.900%
Medtronic PLC 290,580 13,813,200 2.700%
Celgene Corp 174,114 13,813,200 2.700%
UnitedHealth Group Inc 188,038 13,301,600 2.600%
AbbVie Inc 318,319 12,790,000 2.500%
Express Scripts Holding Co 209,457 11,255,200 2.200%
Biogen Idec Inc 41,466 10,743,600 2.100%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil